Intensive chemoradiotherapy and autologous bone marrow transplantation for resistant lymphoma
Da, W.M.
Bone Marrow Transplantation 2(1): 112-113
1987
ISSN/ISBN: 0268-3369 PMID: 3332152 Document Number: 290551
Document emailed within 1 workday
Related Documents
Seeger, R.C.; Villablanca, J.G.; Matthay, K.K.; Harris, R.; Moss, T.J.; Feig, S.A.; Selch, M.; Ramsay, N.; Reynolds, C.P. 1991: Intensive chemoradiotherapy and autologous bone marrow transplantation for poor prognosis neuroblastoma Progress in Clinical and Biological Research 366: 527-533Da, W.M.; Zhong, J.T.; Liu, Y.; Huang, Y.S.; Bai, H.; Wu, X.X.; Ou, Y.X.; Wang, C.B.; Xu, S.F. 1993: Prolonged disease-free survival after ablative chemoradiotherapy and autologous bone marrow transplantation in adult malignant lymphoma Chinese Medical Journal 106(4): 277-281
Chapuis, B.; Helg, C.; Aapro, M.; Maurice, P.; Pipard, G.; Wyss, M. 1986: Intensive treatment and autologous bone marrow transplantation in cases of acute leukemia and lymphoma Schweizerische Medizinische Wochenschrift 116(34): 1158-1159
Kessinger, A.; Vose, J.M.; Bierman, P.J.; Armitage, J.O. 1991: High-dose therapy and autologous peripheral stem cell transplantation for patients with bone marrow metastases and relapsed lymphoma: an alternative to bone marrow purging Experimental Hematology 19(10): 1013-1016
Gorin, N.C.; Labopin, M.; Meloni, G.; Korbling, M.; Carella, A.; Herve, P.; Burnett, A.; Rizzoli, V.; Alessandrino, E.P.; Bjorkstrand, B. 1991: Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: further evidence of the role of marrow purging by mafosfamide. European Co-operative Group for Bone Marrow Transplantation (EBMT) Leukemia 5(10): 896-904
Fegan, C.; Thomas, H.; Bailey-Wood, R.; Coleman, S.; Phillips, S.; Hoy, T.; Whittaker, J.A. 1995: In vitro LAK (lymphokine activated killer) activity following autologous peripheral blood stem cell is significantly greater than that following autologous bone marrow and allogeneic bone marrow transplantation Bone Marrow Transplantation 16(2): 277-281
Hernández, M.D.; del Cañizo, M.C.; González, M.; Caballero, M.D.; López-Berges, M.C.; Vázquez, L.; Orfao, A.; Corral, M.; Nieto, M.J.; San Miguel, J.F. 1998: Immune reconstitution after autologous progenitor hemopoietic cell transplantation. a study comparing autologous bone marrow and autologous peripheral blood transplantation Medicina Clinica 110(20): 768-773
Roberts, M.M.; To, L.B.; Gillis, D.; Mundy, J.; Rawling, C.; Ng, K.; Juttner, C.A. 1993: Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation Bone Marrow Transplantation 12(5): 469-475
Peters, W.P.; Ross, M.; Vredenburgh, J.J.; Hussein, A.; Rubin, P.; Dukelow, K.; Cavanaugh, C.; Beauvais, R.; Kasprzak, S. 1994: The use of intensive clinic support to permit outpatient autologous bone marrow transplantation for breast cancer Seminars in Oncology 21(4 Suppl 7: 25-31
Ozsahin, H.; Fabrega, S.; Douay, L.; Barbu, V.; Gorin, N.C. 1990: Application of serum-free liquid bone marrow cultures to bone marrow purging for autologous bone marrow transplantation in acute lymphoblastic leukemia Nouvelle Revue Francaise d'Hematologie 32(5): 353-355
Heal, J.M.; Blumberg, N.; Kirkley, S.A.; DiPersio, J.F.; Rapoport, A.P.; Rowe, J.M. 1994: Leukocyte-reduced transfusions of ABO-identical platelets and clinical outcome in autologous bone marrow transplantation for lymphoma Bone Marrow Transplantation 14(6): 943-948
Visani, G.; Dinota, A.; Verlicchi, F.; Bandini, G.; Ricci, P.; Motta, M.R.; Rizzi, S.; Lemoli, R.M.; Poluzzi, C.; Gherlinzoni, F. 1988: Autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma: comparison of different parameters in predicting the kinetics of haematological recovery Bone Marrow Transplantation 3(6): 599-605
Brynes, R.K.; Wilson, C.S.; Kim, A.B.; McCourty, A. 1997: Expression of p53, MDM2, p21waf1, bcl-2, and retinoblastoma gene proteins in myelodysplastic syndrome after autologous bone marrow transplantation for lymphoma Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 10(11): 1120-1127
Slavin, S.; Nagler, A. 1997: Cytokine-mediated immunotherapy following autologous bone marrow transplantation in lymphoma and evidence of interleukin-2-induced immunomodulation in allogeneic transplants Cancer Journal from Scientific American 3(Suppl 1): S59-S67
De Kreuk, M.; Ossenkoppele, G.J.; Meijer, C.J.; Huijgens, P.C. 1996: Prognostic factors for survival of non-Hodgkin's lymphoma patients treated with high-dose chemotherapy and autologous bone marrow transplantation Bone Marrow Transplantation 17(6): 963-971
Duhamel, G.; Gorin, N.C.; Douay, L.; Najman, A.; Stachowiak, J. 1982: Bone marrow repopulation after heavy chemotherapy and autologous bone marrow transplantation. Monitoring with biopsies and marrow culture on agar La Nouvelle Presse Medicale 11(11): 833-836
Schrøder, H.; Clausen, N.; Thorling, K.; Hokland, P. 1993: Autologous bone marrow transplantation in children with malignant diseases. Bone marrow harvest and procedure-related toxicity Ugeskrift for Laeger 155(20): 1536-1539
Bolwell, B.J.; Fishleder, A.; Andresen, S.W.; Lichtin, A.E.; Koo, A.; Yanssens, T.; Burwell, R.; Baucco, P.; Green, R. 1993: G-CSF primed peripheral blood progenitor cells in autologous bone marrow transplantation: parameters affecting bone marrow engraftment Bone Marrow Transplantation 12(6): 609-614
Oudshoorn, M.; Falkenburg, J.H.; Ebeling, L.J.; Haak, H.L.; Wijermans, P.W.; Fibbe, W.E.; Willemze, R.; van Rood, J.J. 1996: Unrelated bone marrow transplantation as a rescue procedure following inadvertent loss of an autologous bone marrow graft Bone Marrow Transplantation 18(2): 461-463
Chang, J.; Morgenstern, G.R.; Coutinho, L.H.; Scarffe, J.H.; Carr, T.; Deakin, D.P.; Testa, N.G.; Dexter, T.M. 1989: The use of bone marrow cells grown in long-term culture for autologous bone marrow transplantation in acute myeloid leukaemia: an update Bone Marrow Transplantation 4(1): 5-9